KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 138 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,379 | -98.9% | 563 | -98.5% | 0.00% | – |
Q1 2023 | $120,198 | -99.1% | 38,402 | -97.6% | 0.00% | -100.0% |
Q2 2022 | $13,301,000 | -64.7% | 1,608,400 | -29.0% | 0.06% | -62.4% |
Q1 2022 | $37,649,000 | +6.9% | 2,265,287 | +7.6% | 0.15% | +5.7% |
Q4 2021 | $35,204,000 | +863.4% | 2,105,490 | +922.1% | 0.14% | +729.4% |
Q1 2019 | $3,654,000 | +23.9% | 206,000 | +64.8% | 0.02% | +21.4% |
Q4 2018 | $2,950,000 | – | 125,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |